Analysis of viral and cellular parameters which affect the fusion process of influenza viruses.
In the present investigation we studied the fusogenic process developed by influenza A, B and C viruses on cell surfaces and different factors associated with virus and cell membrane structures. The biological activity of purified virus strains was evaluated in hemagglutination, sialidase and fusion assays. Hemolysis by influenza A, B and C viruses ranging from 77.4 to 97.2%, from 20.0 to 65.0% from 0.2 to 93.7% and from 9.0 to 76.1% was observed when human, chicken, rabbit and monkey erythrocytes, respectively, were tested at pH 5.5. At this pH, low hemolysis indexes for influenza A, B and C viruses were observed if horse erythrocytes were used as target cells for the fusion process, which could be explained by an inefficient receptor binding activity of influenza on N-glycolyl sialic acids. Differences in hemagglutinin receptor binding activity due to its specificity to N-acetyl or N-glycolyl cell surface oligosaccharides, density of these cellular receptors and level of negative charges on the cell surface may possibly explain these results, showing influence on the sialidase activity and the fusogenic process. Comparative analysis showed a lack of dependence between the sialidase and fusion activities developed by influenza B viruses. Influenza A viruses at low sialidase titers (< 2) also exhibited clearly low hemolysis at pH 5.5 (15.8%), while influenza B viruses with similarly low sialidase titers showed highly variable hemolysis indexes (0.2 to 78.0%). These results support the idea that different virus and cell-associated factors such as those presented above have a significant effect on the multifactorial fusion process.
Departamento de Virologia, Instituto de Microbiologia Prof. Paulo de Góes, Universidade Federal do Rio de Janeiro, Brasil.
A T
AT
Barbosa
M O
MO
Luiz
N P
NP
Gusmão
J N
JN
Couceiro
D000818:Animals; D004910:Erythrocyte Membrane; D009980:Influenza A virus / Q000472:pathogenicity*; D009981:Influenza B virus / Q000472:pathogenicity*; D009982:Gammainfluenzavirus / Q000472:pathogenicity*; D008561:Membrane Fusion / Q000276:immunology*; D008562:Membrane Glycoproteins; D009439:Neuraminidase; D009976:Orthomyxoviridae Infections / Q000503:physiopathology; D010222:Parainfluenza Virus 1, Human / Q000472:pathogenicity*; D011817:Rabbits; D012794:Sialic Acids; D014760:Viral Fusion Proteins
D008562:Membrane Glycoproteins; D012794:Sialic Acids; D014760:Viral Fusion Proteins; D009439:Neuraminidase